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Abstract Surgical closure of the ventricular septal defect is
the most commonly performed procedure in pediatric cardiac
surgery. There are conflicting data on weight at operation as
risk factor for a complicated course. We performed a retro-
spective evaluation of mortality and morbidity in all patients
undergoing surgical ventricular septal defect closure at our
institution between 2004 and 2012 to identify risk factor for a
complicated course.Multivariate logistic regressionmodeling
was performed to identify risk factors for a complicated
course. 243patientswhounderwent surgical ventricular septal
defect closure were included. Median age at operation was
168.0 days (range 17–6898), themedianweight 6.0 kg (range
2.1–102.0). No deaths occurred. Two patients (0.8%) required
a pacemaker for permanent heart block. Five patients (2.1%)
underwent reoperation for a hemodynamically important
residual ventricular septal defect. No other major adverse
events occurred. No risk factors for major adverse events
could be established.Multivariate analysis identified a genetic
syndrome, long bypass time and low weight at operation as
independent risk factors for a prolonged intensive care stay
([1 day) and prolonged ventilation time ([6 h). Contempo-
rary results of surgical VSD closure are excellent with no
mortality and low morbidity in this series. Although it is
associated with increased ventilation time and a longer hos-
pital stay, low bodyweight at operation is not associated with
an increased risk of complications or major adverse events in
our series.
Keywords Ventricular septal defect  Congenital heart
disease  Cardiac surgery  Risk factors  Pediatric
cardiology  Pediatric cardiac surgery
Introduction
With an incidence of 2–5%, the ventricular septal defect
(VSD) is the most common congenital malformation of the
heart [1, 2]. Therefore, VSD repair is the most commonly
performed pediatric cardiac operation. Recent reports have
indicated a very low incidence of postoperative complications
[3]. Nevertheless complications still occur and it is important
to identify associated risk factors. With the introduction of
device closure ofVSD, contemporary results of surgical repair
are necessary to provide current benchmarks of treatment.
Recently Anderson et al. [4] found that young age
(\6 months) and low bodyweight were risk factors for
complications. This, however, contrasts with data published
by Kogon et al. [5]. Therefore, risk factors for a complicated
course after VSD closure vary between centers.
The purpose of this study is to evaluate the results of
surgical VSD closure in a recent single center cohort and to
define risk factors for a complicated course.
Patients and Methods
Patients
All patients who underwent surgical closure of a simple
VSD between March 1, 2004 and December 31, 2012 at the
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Children’s Hospital, University Medical Center Utrecht,
The Netherlands, were retrospectively reviewed. A simple
VSD was defined as an isolated VSD or a VSD with
concomitant atrial septal defect/ patent foramen ovale,
patent ductus arteriosus or mildly stenotic/regurgitant
semilunar valves. VSD closure was the main indication for
surgical intervention in all patients. Patients with prior
pulmonary artery banding were also included. Patients with
more complex cardiac anomalies, including atrioventricu-
lar septal defect, coarctation of the aorta, severe stenosis or
insufficiency of the semilunar valves and tetralogy of
Fallot, were excluded. Medical records of these patients
were retrospectively reviewed with permission from the
institutional review board of the University Medical Center
Utrecht, The Netherlands.
Two hundred forty-three patients met the inclusion cri-
teria. We collected preoperative, perioperative and post-
operative data from the echocardiography reports,
perfusion reports, clinic, inpatient and operative notes for
all the patients. Outcomes were assessed through the latest
postoperative visit before inclusion. All patients that met
the inclusion criteria were analyzed.
The preoperative characteristics, including sex, gesta-
tional age, birth weight, cardiac and non-cardiac comorbid-
ity, age at operation, bodyweight at operation, days in
hospital preoperatively, days ventilated preoperatively, type
of VSD, indication for surgery, product of multiple gestation
and underlying genetic condition, were examined. Follow-
up duration was calculated in years using the date of opera-
tion and the date of the start of the database. VSD types were
subdivided in four groups, perimembranous, muscular,
doubly committed and multiple based on transthoracic
echocardiography. The indications for operation were
organized in three groups: volume load (failure to thrive or
congestive heart failure), obstruction (right ventricular out-
flow tract obstruction, aortic insufficiency or double-cham-
ber right ventricle) and pulmonary (elevated pulmonary
vascular resistance). This classification was based on the
information provided by the referring cardiologists.
The surgical technique used, surgeon who operated,
cross-clamp and bypass times and the need for a second
bypass run were assessed as operative factors. Surgical
techniques were primary closure and patch closure.
Surgical outcome and complications were assessed
according to international standards [6] and included length
of stay, length of postoperative ventilation, residual VSD
(defined as flow across the ventricular septum by echocar-
diography directly after operation or at first outpatient clinic
visit), incidence of reoperation for a significant residual
VSD, reintubation, refixation of the sternum, wound infec-
tion, post-pericardiotomy syndrome, chylothorax, transient
or complete heart block, seizure, rehospitalization, circula-
tory arrest, stroke, renal failure, neurological deficit,
paralyzed diaphragm, need for postoperative mechanical
circulatory support and death. Unintended reoperation, heart
block requiring a permanent pacemaker, circulatory arrest
and death were considered major adverse events.
Surgical Technique
Median sternotomy was the used surgical approach in all
patients. All patients underwent cardiopulmonary bypass.
Four surgeons from the Children’s Hospital, University
Medical Center Utrecht, The Netherlands performed the
surgeries (three surgeons performed 97.5% of the surgeries).
The surgeon decided whether primary closure or closure
with a patch was indicated based on their own expertise.
During the same operation, the surgeon also performed atrial
septal defect closure, patent foramen ovale closure, patent
ductus arteriosus ligation, infundibular muscle resection,
valvuloplasty and/or division when needed.
Before the operation, all patients underwent transtho-
racic echocardiography during outpatient clinic visits. All
patients received an epicardial or a transesophageal
echocardiographic re-evaluation just prior to surgery. An
outcome echo was made right after VSD closure during
ultrafiltration to assess the surgical result. Postoperatively
all patients underwent another transthoracic echocardiog-
raphy during hospital stay prior to discharge.
Statistical Analysis
Statistical analyses were performed using IBM SPSS Statis-
tics (version 20.0.0). The Kolmogorov-Smirnov test was used
to verify whether our data were normally distributed or not.
Onlybirthweight and the logarithmof aortic cross-clamp time
and bypass time were normally distributed, all the other
continuous variables were non-normally distributed. For the
normally distributed data, we used means and standard devi-
ations to describe the variables, for the not normally dis-
tributed data we used medians and ranges to describe the
variables. Frequencies and percentages were used for cate-
gorical data. For analysis the unequally distributed variables
were dichotomized. Univariate analysis was done using a
univariate logistic regression model. Determinants that were
univariately associated (P\ 0.1) with the outcome were
included in a multivariate logistic regression model to verify
whether they were independent predictors.
Results
Patient Characteristics
A total of 243 patients underwent surgical VSD closure
during the study period. Patient characteristics are
Pediatr Cardiol (2017) 38:264–270 265
123
presented in Table 1. Forty-nine percent of patients were
male. Median age at operation was 168 days with a cor-
responding median bodyweight at operation of 6.0 kg.
Fifty-three percent of the patients was 6 months or younger
at the time of operation. An underlying genetic syndrome
was present in 18.1%. Concomitant anomalies were found
in multiple patients. Mean follow-up duration was
3.1 years.
Operative Characteristics
Table 2 lists the operative characteristics. 205 patients
were outpatient before surgery. Two hundred thirty-three
patients were not ventilator dependent preoperatively. Two
patients had a postoperative intensive care unit (ICU) stay
of more than 8 days. One patient had an ICU stay of
21 days due to failure to extubate because of laryngotra-
cheobronchomalacia. Another patient had an ICU stay of
31 days because of a big muscular VSD which remained
unnoticed during surgery of the target VSD which caused
pulmonary hypertension, combined with pneumonia and
upper respiratory tract infection. A total of 188 patients had
a total postoperative stay of 1 week or less. In most cases
an infection (mostly respiratory tract) was the cause of a
prolonged stay. The majority of patients were extubated
within 24 h (n = 210), 31 patients were extubated within
6 days. The two patients with a prolonged ICU stay were
ventilated for 20 and 28 days, respectively. In 124 patients
(51%) postoperative transesophageal or transthoracic
echocardiography showed residual Doppler signals across
the septum indicating residual VSD. The majority of
defects were very small. Most of these residual shunts
(71%) disappeared during a mean follow-up period of
3.1 years.
Complications
Table 3 summarizes the examined complications. Two
percent of all patients needed reoperation because of a
significant residual VSD. One patient had a seizure 1 day
postoperatively. The cause of the seizure remained
unclear. There was no permanent neurologic deficit
afterward. The 30 day and in hospital mortality was 0%.
Two patients died during late follow-up. One patient died
4 months after the operation during a readmission for
pulmonary hypertensive crisis caused by previously
undiagnosed severe pulmonary vein stenosis. The other
patient died of severe dehydration 15 months after the
surgery. These deaths were considered to be unrelated to
VSD closure. In total 15.6% of the patients had one or
more complications, whereas 2.9% of all patients had a
major adverse event.
Table 1 Patient characteristics
(n = 243)
Sex
Boy (%) 118 (48.6)
Girl (%) 125 (51.4)
Gestational age (weeks, median with min–max)a 39.0 (29–42)
Birth weight (g, mean with SD)b 3 141 (±778)
Weight at operation (g, median with min–max) 6 000 (2100–102,000)
Age at operation (days, median with min–max) 168 (17–6898)
Age groups
B 6 months (%) 128 (52.7)
[6 months (%) 115 (47.3)
Genetic syndrome
Trisomy 21 (%) 31 (12.8)
22q11 (%) 3 (1.2)
Other (%) 10 (4.1)
Concomitant cardiac defects
Patent foramen ovale (%) 55 (22.6)
Atrial septal defect (%) 53 (21.8)
Patent ductus arteriosus (%) 30 (12.3)
Pulmonary valve stenosis (%) 18 (7.4)
Follow-up duration (years, median with min–max) 3.1 (0.3–9.1)
SD standard deviation
a n = 227, from 16 patients gestational age was unknown
b n = 228, from 15 patients birth weight was unknown
266 Pediatr Cardiol (2017) 38:264–270
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Predictors
A univariate analysis was performed to determine risk
factors for a prolonged postoperative stay (ICU and total
duration of stay), prolonged duration on mechanical ven-
tilation, complications, major adverse events and postop-
erative infections other than wound infection (Table 4). A
prolonged postoperative stay at the ICU was defined as a
stay of more than one day. A prolonged postoperative stay
in total was defined as a stay of more than 1 week. A
prolonged duration on mechanical ventilation was defined
as mechanical ventilation more than 6 h after surgery.
Variables that were not normally distributed were dichot-
omized. Due to the rarity of complications and major
adverse events multivariate analysis could only be per-
formed for the duration of postoperative ICU stay, total
length of stay and postoperative ventilation time (Table 5).
A longer postoperative stay in total was predicted by the
presence of a genetic syndrome, a weight of\6.0 kg, a
longer aortic cross-clamp or bypass time and a postopera-
tive infection other than wound infection. When analyzed
multivariately weight at operation and a longer bypass time
were still predictors for a longer postoperative hospital
stay.
Patients with a genetic syndrome, with a weight of
\6.0 kg at operation, with a longer bypass or cross-clamp
time during operation and patients operated on before
01-01-2009 were more likely to have a longer stay at the
ICU and a longer ventilation time. In the multivariate
analysis a genetic syndrome, weight of\6.0 kg at opera-
tion and a longer bypass time again were identified as
predictors for a longer postoperative stay at the ICU and a
longer ventilation time.
In the univariate analysis no predictors were found for
complications, major adverse events and postoperative
infections.
Discussion
Contemporary Results
This study shows that the contemporary results of surgical
VSD closure are excellent. There was no mortality and
major adverse events occurred only in 2.9% of patients.
These results are comparable with results of other recent
Table 2 Operative characteristics (n = 243)
Indication for operation
Volume load (%) 168 (69.1)
Obstruction (%) 52 (21.4)
Pulmonary (%) 23 (9.5)
Ventricular septal defect type
Perimembranous (%) 192 (79)
Muscular (%) 14 (5.8)
Doubly committed (%) 24 (9.9)
Multiple (%) 13 (5.3)
Surgical technique
Primary closure (%) 47 (19.3)
Patch (%) 196 (80.7)
Hospitalization (days)
Preoperative (median with min–max) 0.0 (0–78)
Postoperative ICU (median with min–max) 1.0 (1–31)
Postoperative total (median with min–max) 5.0 (3–65)
Mechanical ventilation (days)
Preoperative (median with min–max) 0.0 (0–40)
Postoperative (median with min–max) 0.3 (0–28)
Bypass time (min, mean with SD) 63.5 (±22.5)
Aortic cross-clamp time (min, mean with SD) 41.2 (±18.1)
Indications for operation were volume load (failure to thrive or
congestive heart failure), obstruction (right ventricular outflow tract
obstruction, aortic insufficiency or double-chamber right ventricle) or
pulmonary (elevated pulmonary vascular resistance)
SD standard deviation
Table 3 Complications (n = 243)
Reintubation (%) 7 (2.9)
Reoperation for a significant residual VSD (%) 5 (2.1)
Refixation of the sternum (%) 6 (2.5)
Wound infection (%) 4 (1.6)
Postpericardiotomy syndrome (%) 4 (1.6)
Chylothorax (%) 1 (0.4)
Heart block
Transient (%) 12 (4.9)
Permanenta (%) 2 (0.8)
Seizure (%) 1 (0.4)
Rehospitalization (%) 6 (2.5)
Circulatory arrest (%) 0 (–)
Stroke (%) 0 (–)
Renal failure (%) 0 (–)
Neurological deficit (%) 0 (–)
Paralyzed diaphragm (%) 0 (–)
Need for postoperative mechanical circulatory support 0 (–)
Death (%) 0 (–)
Total complicationsb (%) 38 (15.6)
Total major adverse eventc (%) 7 (2.9)
a Requiring pacing by a pacemaker
b Number of patients with one or more complications
c Accounted as major adverse events are reoperation, permanent
heart block, circulatory arrest or death
Pediatr Cardiol (2017) 38:264–270 267
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studies [3–5, 7]. Currently, data on mortality for congenital
heart surgery in Europe are collected in the European
Association for Cardio-Thoracic Surgery (EACTS) Con-
genital Database. This database shows a 30 day mortality
of 1.38% for patch repair and 1.84% for primary closure
with a hospital mortality of, respectively, 1.57 and 2.17%
[8]. Major adverse events are not yet registered in this
database. Surgical VSD closure is a very safe procedure,
and future studies should aim to further reduce complica-
tions and serious adverse events.
Complications
Other studies show comparable results regarding the
number of complications with permanent heart block
occurring in 0.0–2.1% (0.85% this study) and reoperation
in 0.0–4.9% (2.1% this study) [3–5, 7].
We found a high percentage of initial residual VSD’s of
51.0% in the present study. However, spontaneous closure
occurred in 71.0% of these residual VSD’s during a limited
follow-up period (mean of 3.1 years). Therefore, the
eventual rate of spontaneous closure will probably even be
higher. Reoperation for a hemodynamically important
residual VSD, however, is extremely rare (2.1%). Other
than endocarditis prophylaxis in case of patch closure, a
hemodynamically insignificant residual VSD has no clini-
cal consequences. Other studies reported residual VSD’s in
different ways, with varying follow-up duration. One study
found a residual VSD in 16% of the patients after a mean
follow-up of 1.1 years, without reporting the initial count
of residual VSD’s [3], whilst another study found residual
VSD’s in 8% of the patients after a follow-up duration of
12 years [9], reporting the same count after a follow-up
duration of more than 20 years [10]. These data suggest
that spontaneous closure of residual VSD’s occurs rela-
tively early after surgery. Our high rate of residual VSD’s
may also be the result of the routine performance of
transesophageal echocardiography in all patients that
undergo cardiac surgery regardless of age. The trans-
esophageal echocardiography microprobe that is used in
small infants is not yet widely used. It allows us to detect
even small residual VSD’s in the operating theater that may
have spontaneously closed at the first postoperative
transthoracic echocardiography.
Risk Factors for Complications
A recent study showed that low bodyweight remains a
significant predictor of morbidity [4]. This could not be
confirmed by the present study. Our study had a low
complication rate; therefore, only univariate analyses could
be performed which showed that there was no significant
risk factor for major adverse events or complications in
general, including lower bodyweight or age. Our results
suggest that surgical VSD closure should not be postponed
for weight gain of the low bodyweight patients. However,
the odds ratio for a weight\6.0 kg at operation for the risk
at complications was 2.06 (95% CI 1.00–4.25) with a
P value of 0.051; therefore, future research is needed to
support this conclusion.
The current study shows that low bodyweight at oper-
ation is associated with a longer postoperative stay at the
ICU and a longer postoperative ventilation time. This is in
accordance with two other studies [4, 7], but denied by one
other study stating that bodyweight does not influence
these aspects [5].
In summary low bodyweight will prolong hospital stay
but is not associated with complications or major adverse
events. Therefore, surgical VSD closure is considered a
safe procedure in all patients regardless of their
bodyweight.
Patients with a genetic defect are also at risk for a longer
postoperative stay at the ICU and a longer postoperative
ventilation time. This may well be explained by
Table 5 Multivariate analyses: riskfactors for a longer stay or ventilation time
Post-op time in total[1 week Post-op time at ICU[1 day Post-op ventilation time[6 h
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Genetic syndrome 2.07 (0.89–4.83) 0.092 3.13 (1.45–6.79) 0.004 2.45 (1.15–5.23) 0.020
Indication for operationa
Obstruction 0 0.997 0.48 (0.18–1.27) 0.138 0.47 (0.17–1.32) 0.151
Pulmonary 0.60 (0.20–1.76) 0.347 1.35 (0.50–3.68) 0.558 1.35 (0.51–3.59) 0.548
Weight at operation\6000 g 5.28 (2.12–13.17) \0.001 3.37 (1.72–6.60) \0.001 3.57 (1.80–7.09) \0.001
Longer bypass time 12.05 (3.51–41.33) \0.001 4.52 (1.67–12.20) 0.003 3.94 (1.47–10.59) 0.006
Indications for operation were volume load (failure to thrive or congestive heart failure), obstruction (right ventricular outflow tract obstruction,
aortic insufficiency or double-chamber right ventricle) or pulmonary (elevated pulmonary vascular resistance)
OR odds ratio, 95% CI 95% confidence interval
a Reference group is the indication for operation volume load
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complicating anomalies associated with the genetic defect
as reported in previous studies [4].
Future Perspectives
Only one study group described the long-term effects of
surgical repair of a VSD at young age [10, 11]. According
to the first study [10], patients may be at higher risk for a
sick-sinus syndrome as 4% developed this after a mean
follow-up of fifteen years. Aortic regurgitation was another
late complication that was described in 16% of all patients
in this study. This study described 22–34 years of follow-
up from operations that took place between 1968 and 1980.
The second study of the same cohort [11] with a follow-up
up to 40 years shows systolic dysfunction of the left ven-
tricle in 21% and systolic dysfunction of the right ventricle
in 17%. The percentage of aortic regurgitation went up to
21%. The postoperative mortality rate at that time was high
(14%). Surgical technique and pre- and postoperative care
have improved dramatically since that era given the current
mortality rate of 0%. It is unknown if these long-term
complications will appear in our cohort. It would be
interesting to evaluate late echocardiographic results in our
patients. New long-term follow-up studies should be per-
formed to see whether the long-term outcome has changed.
Our aim was to define risk factors for complications and
major adverse events. Because complications and major
adverse events are rare, multivariate analysis was not
possible in our study. In order to actually define risk factors
for complications and major adverse events future research
with larger cohorts should be conducted.
Limitations
The limitations of this study are primarily defined by the
limitations of all retrospective chart studies. In a prospec-
tive study more information could be assessed and the
length of follow-up could be more consistent. Secondary
this was a single institutional experience so our findings
may not be applicable to other centers.
Conclusion
Contemporary results of surgical VSD closure are excellent
with no mortality and low morbidity in this series.
Although it is associated with increased ventilation time
and a longer hospital stay low bodyweight at operation is
not associated with an increased risk of complications or
major adverse events in our series.
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